Covid19 Clinical Trial
Official title:
Use of Lung Ultrasound in Evaluating Physiological Response to Awake Self Proning
NCT number | NCT04855162 |
Other study ID # | 21040601 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | July 21, 2021 |
Est. completion date | October 23, 2021 |
Verified date | November 2021 |
Source | Rush University Medical Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The primary objective of this study is to explore the physiological mechanism of awake, self proning among patients with acute hypoxemic respiratory failure induced by COVID-19, using LUS in the first three days and explore the predictive value of LUS in patients' outcome.
Status | Completed |
Enrollment | 74 |
Est. completion date | October 23, 2021 |
Est. primary completion date | October 7, 2021 |
Accepts healthy volunteers | |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: 1. Adult subjects 18 years and older, 2. Confirmed COVID-19 diagnosis 3. Acute hypoxemic respiratory failure (SpO2/FiO2 or PaO2/FiO2 <300) 4. Ordered self-prone positioning per medical team Exclusion Criteria: 1. Pregnant 2. Palliative care |
Country | Name | City | State |
---|---|---|---|
Mexico | Hospital Civil Fray Antonio Alcalde | Guadalajara | Jalisco |
United States | Rush University Medical Center | Chicago | Illinois |
Lead Sponsor | Collaborator |
---|---|
Rush University Medical Center | Hospital Civil de Guadalajara |
United States, Mexico,
Avdeev SN, Nekludova GV, Trushenko NV, Tsareva NA, Yaroshetskiy AI, Kosanovic D. Lung ultrasound can predict response to the prone position in awake non-intubated patients with COVID-19 associated acute respiratory distress syndrome. Crit Care. 2021 Jan 25;25(1):35. doi: 10.1186/s13054-021-03472-1. — View Citation
Langer T, Brioni M, Guzzardella A, Carlesso E, Cabrini L, Castelli G, Dalla Corte F, De Robertis E, Favarato M, Forastieri A, Forlini C, Girardis M, Grieco DL, Mirabella L, Noseda V, Previtali P, Protti A, Rona R, Tardini F, Tonetti T, Zannoni F, Antonelli M, Foti G, Ranieri M, Pesenti A, Fumagalli R, Grasselli G; PRONA-COVID Group. Prone position in intubated, mechanically ventilated patients with COVID-19: a multi-centric study of more than 1000 patients. Crit Care. 2021 Apr 6;25(1):128. doi: 10.1186/s13054-021-03552-2. — View Citation
Wang XT, Ding X, Zhang HM, Chen H, Su LX, Liu DW; Chinese Critical Ultrasound Study Group (CCUSG). Lung ultrasound can be used to predict the potential of prone positioning and assess prognosis in patients with acute respiratory distress syndrome. Crit Care. 2016 Nov 30;20(1):385. — View Citation
Weiss TT, Cerda F, Scott JB, Kaur R, Sungurlu S, Mirza SH, Alolaiwat AA, Kaur R, Augustynovich AE, Li J. Prone positioning for patients intubated for severe acute respiratory distress syndrome (ARDS) secondary to COVID-19: a retrospective observational co — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | SpO2/FiO2 pre prone in day 1 | Patients' response of oxygenation using SpO2/FiO2 | pre prone in day 1 | |
Primary | SpO2/FiO2 post prone in day 1 | Patients' response of oxygenation using SpO2/FiO2 | post prone in day 1 | |
Primary | SpO2/FiO2 pre prone in day 2 | Patients' response of oxygenation using SpO2/FiO2 | Pre prone in day 2 | |
Primary | SpO2/FiO2 post prone in day 2 | Patients' response of oxygenation using SpO2/FiO2 | Post prone in day 2 | |
Primary | SpO2/FiO2 pre prone in day 3 | Patients' response of oxygenation using SpO2/FiO2 | Pre prone in day 3 | |
Primary | SpO2/FiO2 post prone in day 3 | Patients' response of oxygenation using SpO2/FiO2 | Post prone in day 3 | |
Primary | Lung Ultrasound Score pre prone in day 1 | Patients' response of oxygenation using Lung ultrasound score | Pre prone in day 1 | |
Primary | Lung Ultrasound Score post prone in day 1 | Patients' response of oxygenation using Lung ultrasound score | Post prone in day 1 | |
Primary | Lung Ultrasound Score pre prone in day 2 | Patients' response of oxygenation using Lung ultrasound score | Pre prone in day 2 | |
Primary | Lung Ultrasound Score post prone in day 2 | Patients' response of oxygenation using Lung ultrasound score | Post prone in day 2 | |
Primary | Lung Ultrasound Score pre prone in day 3 | Patients' response of oxygenation using Lung ultrasound score | Pre prone in day 3 | |
Primary | Lung Ultrasound Score post prone in day 3 | Patients' response of oxygenation using Lung ultrasound score | Post prone in day 3 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05047692 -
Safety and Immunogenicity Study of AdCLD-CoV19-1: A COVID-19 Preventive Vaccine in Healthy Volunteers
|
Phase 1 | |
Recruiting |
NCT04395768 -
International ALLIANCE Study of Therapies to Prevent Progression of COVID-19
|
Phase 2 | |
Terminated |
NCT04555096 -
A Trial of GC4419 in Patients With Critical Illness Due to COVID-19
|
Phase 2 | |
Completed |
NCT04506268 -
COVID-19 SAFE Enrollment
|
N/A | |
Completed |
NCT04508777 -
COVID SAFE: COVID-19 Screening Assessment for Exposure
|
||
Completed |
NCT04961541 -
Evaluation of the Safety and Immunogenicity of Influenza and COVID-19 Combination Vaccine
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT04546737 -
Study of Morphological, Spectral and Metabolic Manifestations of Neurological Complications in Covid-19 Patients
|
N/A | |
Completed |
NCT04494646 -
BARCONA: A Study of Effects of Bardoxolone Methyl in Participants With SARS-Corona Virus-2 (COVID-19)
|
Phase 2 | |
Terminated |
NCT04542993 -
Can SARS-CoV-2 Viral Load and COVID-19 Disease Severity be Reduced by Resveratrol-assisted Zinc Therapy
|
Phase 2 | |
Completed |
NCT04532294 -
Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Neutralizing Antibody in Healthy Participants
|
Phase 1 | |
Not yet recruiting |
NCT04543006 -
Persistence of Neutralizing Antibodies 6 and 12 Months After a Covid-19
|
N/A | |
Terminated |
NCT04581915 -
PHRU CoV01 A Trial of Triazavirin (TZV) for the Treatment of Mild-moderate COVID-19
|
Phase 2/Phase 3 | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Completed |
NCT04387292 -
Ocular Sequelae of Patients Hospitalized for Respiratory Failure During the COVID-19 Epidemic
|
N/A | |
Not yet recruiting |
NCT04527211 -
Effectiveness and Safety of Ivermectin for the Prevention of Covid-19 Infection in Colombian Health Personnel
|
Phase 3 | |
Completed |
NCT04537663 -
Prevention Of Respiratory Tract Infection And Covid-19 Through BCG Vaccination In Vulnerable Older Adults
|
Phase 4 | |
Completed |
NCT04979858 -
Reducing Spread of COVID-19 in a University Community Setting: Role of a Low-Cost Reusable Form-Fitting Fabric Mask
|
N/A | |
Not yet recruiting |
NCT05038449 -
Study to Evaluate the Efficacy and Safety of Colchicine Tablets in Patients With COVID-19
|
N/A | |
Completed |
NCT04610502 -
Efficacy and Safety of Two Hyperimmune Equine Anti Sars-CoV-2 Serum in COVID-19 Patients
|
Phase 2 | |
Active, not recruiting |
NCT06042855 -
ACTIV-6: COVID-19 Study of Repurposed Medications - Arm G (Metformin)
|
Phase 3 |